Glenmark Pharmaceuticals

| Updated on January 23, 2018 Published on May 19, 2015

Glenmark Pharmaceuticals has informed the exchanges that the board of directors on Tuesday allotted 1.08 crore equity shares of face value ₹1 each at a price of ₹875 a share to Aranda Investments (Mauritius) Pte Ltd on preferential basis. Shares of Glenmark Pharma slipped about 0.7 per cent at ₹899.60 on the NSE.

Published on May 19, 2015
This article is closed for comments.
Please Email the Editor